Managing Oral Anticoagulation Therapy to Reduce Risk of Stroke in NVAF Patients
hosted byPrime Education, LLCManaging Oral Anticoagulation Therapy to Reduce Risk of Stroke in NVAF Patients is organized by Prime Education, LLC.
Release Date: August 25, 2023
Expiration Date: August 24, 2024
Description:
Patients with non-valvular atrial fibrillation (NVAF) are at increased risk of suffering a stroke. Effective use of direct oral anticoagulation (DOAC) therapies reduces this risk. Test your clinical skills in anticoagulant therapy management for an NVAF patient in this interactive clinical case challenge. See how you stack up against your peers as you consider treatment strategies and review expert narratives on the latest evidence in NVAF management.
Learning Objectives:
• Apply the 2021-2022 USPSTF recommendation on aspirin use for the prevention of cardiovascular disease to the management of patients with NVAF
• Assess the impact on cardiovascular outcomes associated with undertreatment and nontreatment of NVAF with oral anticoagulation
• Evaluate the latest clinical safety and efficacy data on oral anticoagulation and concomitant aspirin therapy for NVAF
• Align clinical practices with current evidence and guidelines for stroke prevention in patients with NVAF based on patient-specific factors
• Engage patients in shared decision-making discussions that involve individual patient's risk factors, treatment goals, and preferences
• Employ interprofessional practices for patient monitoring and care coordination among NVAF care teams to mitigate adverse bleeding events and support patient adherence
